Westminster Pharmaceuticals, LLC. Issues Voluntary Nationwide Recall of Levothyroxine and Liothyronine (Thyroid Tablets, USP) Due to Risk of Adulteration

FDA Warns Only 5 Chemists in One Critical Lab – Result of Shutdown

Westminster Pharmaceuticals, LLC is voluntarily recalling all lots, in comeback, of Levothyroxine and Liothyronine (Thyroid Tablets, USP) 15 mg, 30 mg, 60 mg, 90 milligrams, & 120 milligrams to your wholesale level. These goods have been recalled as a precaution as they were fabricated using active pharmaceutical ingredients which were sourced before the FDA’s Import Alert of Sichuan Friendly Pharmaceutical Co., Ltd., which as a consequence of a 2017 review were found to have deficiencies with Current Good Manufacturing Practices (cGMP). Substandard cGMP practices can signify the prospect of danger being introduced to the production procedure.

Source link


Please enter your comment!
Please enter your name here